(Q40464886)

20 September 2017

Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. (English)

1 reference

20 September 2017

1 reference

Zhen-Hua Jin

1

1 reference

20 September 2017

Tetsuya Kurosu

2

1 reference

20 September 2017

Mitsuko Yamaguchi

3

1 reference

20 September 2017

Ayako Arai

4

1 reference

20 September 2017

Osamu Miura

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

20 September 2017

1 reference

20 September 2017

24

1 reference

20 September 2017

12

1 reference

20 September 2017

1973-1981

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208408

20 September 2017

0 references

cites work

Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Chk1 and Chk2 kinases in checkpoint control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Advances in protein kinase B signalling: AKTion on multiple fronts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

p38 and Chk1 kinases: different conductors for the G(2)/M checkpoint symphony

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Growth factor modulation of p53-mediated growth arrest versus apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Dna damage-induced G(1) arrest in hematopoietic cells is overridden following phosphatidylinositol 3-kinase-dependent activation of cyclin-dependent kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Glycogen synthase kinase 3: an emerging therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Cytokine receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

The glamour and gloom of glycogen synthase kinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Constitutive activation of PI3K is involved in the spontaneous proliferation of primary acute myeloid leukemia cells: direct evidence of PI3K activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Toward maintaining the genome: DNA damage and replication checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Molecular targets of lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Simultaneous detection of cyclin B1, p105, and DNA content provides complete cell cycle phase fraction analysis of cells that endoreduplicate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Glycogen Synthase Kinase-3β (GSK3β) Binds to and Promotes the Actions of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Survival of acute myeloid leukemia cells requires PI3 kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

Targeting the checkpoint kinases: chemosensitization versus chemoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208408

21 January 2018

Identifiers

DOI

10.1038/SJ.ONC.1208408

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference